Hyperpolarized (13)C-Pyruvate to Assess Response to Anti-PD1 Immune Checkpoint Inhibition in YUMMER 1.7 Melanoma Xenografts

There is currently no consensus to determine which advanced melanoma patients will benefit from immunotherapy, highlighting the critical need to identify early-response biomarkers to immune checkpoint inhibitors. The aim of this work was to evaluate in vivo metabolic spectroscopy using hyperpolarize...

Descripción completa

Detalles Bibliográficos
Autores principales: Farah, Chantale, Neveu, Marie-Aline, Bouzin, Caroline, Knezevic, Zorica, Gallez, Bernard, Leucci, Eleonora, Baurain, Jean-François, Mignion, Lionel, Jordan, Bénédicte F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917169/
https://www.ncbi.nlm.nih.gov/pubmed/36768822
http://dx.doi.org/10.3390/ijms24032499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917169/
https://www.ncbi.nlm.nih.gov/pubmed/36768822
http://dx.doi.org/10.3390/ijms24032499

Ejemplares similares